You are here

HCV Action & PHE hepatitis C roadshow in London: Presentations

On 26th June 2015, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in London. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in the capital. Among the speakers were Professor William Rosenberg (Consultant Hepatologist at the Royal Free Hospitall), Professor Paul Cosford (Director of Health Protection and Medical Director at PHE), Will Huxter (Regional Director for Specialised Commissioning, NHS England), Dr Chloe Orkin (HIV and Hepatitis Lead for Royal Barts NHS Trust), and a host of others. These slides are taken from the presentations of the speakers, and provide a host of relevant information for anyone concerned with tackling hepatitis C both locally and nationally.

Related resources

Public Health England published its annual 'Hepatitis C in England' report on 30th May 2020. This reporting document monitors the England's progress towards its goal of eliminating the virus by 2030 and contains breakdowns of how testing and treatment are being delivered by service type, demographic and local area. This year's report notes significant increases in treatment availability over the last few years. It also suggests there have been increases in access to treatment for the people who inject drugs.

This 2020 update on drug-related infectious diseases from the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) aims to provide a comprehensive overview of the current situation with regard to the epidemiological picture of drug-related infectious diseases in Europe up to January 2020. It highlights some recent innovative responses to the problem and argues that early diagnosis through testing as well as improving links to treatment and care are crucial steps towards reaching global health goals.

This report from Public Health England provides an update on the recent epidemiology of hepatitis C in London. Among the report's statistics are an estimate that 63% of people who inject drugs (PWID) in London had ever been infected with hepatitis C in 2018, with 41% of those ever infected having a current hepatitis C infection. It is estimated that 18% of PWID were unaware of their infection (lower than the 35% unaware in England as a whole). In 2017/18, 87% of eligible clients of drug treatment services received a hepatitis C test, a small increase from 86% in 2016/2017.

This report provides an overview of The Hepatitis C Trust's peer-to-peer support work, outlining the various ways the charity's peers supports people at risk of or living with hepatitis C, detailing the results the peer project has achieved and explaining challenges that have been overcome in delivering the programme.